You are right @fungus123 the odds (1 in 7) are mentioned in the trial overview as set out by Southampton on their website. For those who do not have a handle on Imugene's funding of Southampton's Neo-polem trial the overview below will help. It has slightly more info than the Australian Trial site mentioned by another poster earlier. Apologies if this has been posted under another thread - I do not follow them all.
https://www.southampton.ac.uk/ctu/trialportfolio/listoftrials/neopolem.page#trial_overview
Ann: New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS, page-75
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.3¢ | $537.6K | 10.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 207796 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1452903 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |